Structure, Function and Interactions of Tau: Particular Focus on Potential Drug Targets for the Treatment of Tauopathies

被引:5
|
作者
Borna, Hojjat [1 ]
Assadoulahei, Kasim [1 ]
Riazi, Gholamhossein [2 ]
Harchegani, Asghar Beigi [1 ]
Shahriary, Alireza [1 ]
机构
[1] Baqiyatallah Univ Med Sci, Syst Biol & Poisonings Inst, Chem Injuries Res Ctr, Tehran, Iran
[2] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
关键词
Tauopathy; tauopathy treatment; tau interaction partners; structure; function; neurodegeneration disease; MICROTUBULE-ASSOCIATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; PROLYL ISOMERASE PIN1; INTRINSICALLY DISORDERED PROTEIN; ALZHEIMERS-DISEASE BRAIN; TRANSGENIC MOUSE MODEL; HEAT-SHOCK PROTEINS; IN-VITRO; PHOSPHATASE; 2A; PHOSPHORYLATED TAU;
D O I
10.2174/1871527317666180525112008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background & Objective: Neurodegenrative diseases are among the most widespread life-threatening disorders around the world in elderly ages. The common feature of a group of neurodegenerative disorders, called tauopathies, is an accumulation of microtubule associated protein tau inside the neurons. The exact mechanism underlying tauopathies is not well-understood but several factors such as traumatic brain injuries and genetics are considered as potential risk factors. Although tau protein is well-known for its key role in stabilizing and organization of axonal microtubule network, it bears a broad range of functions including DNA protection and participation in signaling pathways. Moreover, the flexible unfolded structure of tau facilitates modification of tau by a wide range of intracellular enzymes which in turn broadens tau function and interaction spectrum. The distinctive properties of tau protein concomitant with the crucial role of tau interaction partners in the progression of neurodegeneration suggest tau and its binding partners as potential drug targets for the treatment of neurodegenerative diseases. Conclusion: This review aims to give a detailed description of structure, functions and interactions of tau protein in order to provide insight into potential therapeutic targets for treatment of tauopathies.
引用
收藏
页码:325 / 337
页数:13
相关论文
共 50 条
  • [21] Potential structure/function relationships of predicted secondary structural elements of tau
    Gamblin, TC
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1739 (2-3): : 140 - 149
  • [22] Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of Schizophrenia
    Chavez-Noriega, Laura E.
    Schaffhauser, Herve
    Campbell, Una C.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (03) : 261 - 281
  • [23] Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
    Schmidt, Frank M.
    Kirkby, Kenneth C.
    Lichtblau, Nicole
    CURRENT NEUROPHARMACOLOGY, 2016, 14 (07) : 674 - 687
  • [24] Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions
    Pinter, Erika
    Pozsgai, Gabor
    Hajna, Zsofia
    Helyes, Zsuzsanna
    Szolcsanyi, Janos
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (01) : 5 - 20
  • [25] Oxidative Stress in the Pathogenesis of Aorta Diseases as a Source of Potential Biomarkers and Therapeutic Targets, with a Particular Focus on Ascending Aorta Aneurysms
    Pisano, Calogera
    Benedetto, Umberto
    Ruvolo, Giovanni
    Balistreri, Carmela Rita
    ANTIOXIDANTS, 2022, 11 (02)
  • [26] Structure Determination of 2 Potential Parasitic Drug Targets of the SAHH Family
    Siponen, Marina
    Wisniewska, Magdalena
    Karlberg, Tobias
    Thorsell, Ann-Gerd
    Weigelt, Johan
    Shuler, Herwig
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2009, 65 : S153 - S153
  • [27] Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer
    Kaboli, Parham Jabbarzadeh
    Rahmat, Asmah
    Ismail, Patimah
    Ling, King-Hwa
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 740 : 584 - 595
  • [28] The metabotropic glutamate receptors: Potential drug targets for the treatment of anxiety disorders?
    Pitsikas, Nikolaos
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723 : 181 - 184
  • [29] Investigating potential drug targets for the treatment of glioblastoma: a Mendelian randomization study
    Hongwei Zhang
    Zixuan Wang
    Xiaolong Qiao
    Jiaxing Wu
    Chuandong Cheng
    BMC Cancer, 25 (1)
  • [30] Structure, Function, and Drug Interactions of Neurotransmitter Transporters in the Postgenomic Era
    Omote, Hiroshi
    Miyaji, Takaaki
    Hiasa, Miki
    Juge, Narinobu
    Moriyama, Yoshinori
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56, 2016, 56 : 385 - 402